Syngen Biotech Co.,Ltd. (8279.TWO)
TWD 114.5
(-9.84%)
TWD 114.5
(-9.84%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 433.55 Million TWD | -14.28% |
| 2022 | 505.8 Million TWD | 32.96% |
| 2021 | 380.42 Million TWD | 11.65% |
| 2020 | 340.73 Million TWD | 10.59% |
| 2019 | 308.11 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 98.13 Million TWD | -2.56% |
| 2024 Q1 | 102.03 Million TWD | 9.92% |
| 2024 Q2 | 100.71 Million TWD | -1.29% |
| 2023 Q3 | 113.72 Million TWD | 5.32% |
| 2023 Q4 | 92.82 Million TWD | -18.38% |
| 2023 FY | - TWD | -14.28% |
| 2023 Q2 | 107.98 Million TWD | -9.28% |
| 2023 Q1 | 119.02 Million TWD | 18.03% |
| 2022 Q4 | 100.83 Million TWD | 0.0% |
| 2022 FY | - TWD | 32.96% |
| 2021 FY | - TWD | 11.65% |
| 2020 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | 1037.54% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | -10.15% |
| Level Biotechnology Inc. | 98.7 Million TWD | -339.249% |
| Sagittarius Life Science Corp | -44.73 Million TWD | 1069.078% |
| NeoCore Technology Co., Ltd. | -72.11 Million TWD | 701.201% |
| TaiMed Biologics Inc. | -25.23 Million TWD | 1818.21% |
| GlycoNex Incorporation | -126.82 Million TWD | 441.848% |
| VBI | -6.97 Million TWD | 6318.531% |
| GeneReach Biotechnology Corp. | -143.69 Million TWD | 401.72% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | -1887.877% |
| SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | 2545.876% |
| Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | 518.43% |
| Visgeneer Inc. | 973 Thousand TWD | -44458.684% |
| Mycenax Biotech Inc. | -339.48 Million TWD | 227.711% |
| Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 53.703% |
| G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | -334.264% |
| Neith Corporation | -33.61 Million TWD | 1389.961% |
| Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 143.745% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | 25060.046% |
| Enimmune corporation | -228.96 Million TWD | 289.356% |
| TaiRx, Inc. | -208.64 Million TWD | 307.795% |
| CHO Pharma, Inc. | -277.73 Million TWD | 256.106% |
| EirGenix Inc. | -664.4 Million TWD | 165.255% |
| BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | -486.648% |
| Sunny Pharmtech Inc. | 69.14 Million TWD | -527.043% |
| Lin BioScience, Inc. | -1.07 Billion TWD | 140.466% |
| BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | 483.318% |
| Feng Chi Biotech Corp. | 34.83 Million TWD | -1144.492% |
| Bio Preventive Medicine Corp. | -62.34 Million TWD | 795.459% |
| Lukas Biomedical Inc. | -26.3 Million TWD | 1748.502% |
| RBC Bioscience Corporation | 36.54 Million TWD | -1086.297% |
| BiOptic Inc. | 65.03 Million TWD | -566.62% |
| BRIM Biotechnology, Inc. | -682.46 Million TWD | 163.528% |
| Shine-On BioMedical Co.,Ltd. | -33 Million TWD | 1413.567% |
| Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | 889.504% |
| Advagene Biopharma Co., Ltd. | -80.07 Million TWD | 641.458% |
| NaviFUS Corp. | -55.79 Million TWD | 877.052% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | 2712.098% |
| Sinew Pharma Inc. | -163.63 Million TWD | 364.96% |
| Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | 804.969% |
| Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | -125.339% |
| Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | 291.265% |
| AP Biosciences Inc | -325.51 Million TWD | 233.192% |
| Medigen Biotechnology Corp. | -1.04 Billion TWD | 141.504% |
| 3D Global Biotech Inc. | -35.84 Million TWD | 1309.496% |
| Pharmosa Biopharm Inc. | 29.13 Million TWD | -1388.349% |
| Intech Biopharm Corporation | -219.58 Million TWD | 297.443% |
| Oneness Biotech Co., Ltd. | -674.22 Million TWD | 164.304% |
| Eusol Biotech Co.,Ltd. | -44.95 Million TWD | 1064.508% |
| TWi Biotechnology, Inc. | -160.85 Million TWD | 369.529% |
| Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 33.861% |
| TCI GENE Inc. | 25.98 Million TWD | -1568.743% |
| MegaPro Biomedical Co., Ltd | -110.63 Million TWD | 491.869% |
| Senhwa Biosciences, Inc. | -283.78 Million TWD | 252.776% |
| Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | 397.017% |
| NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | -3030.368% |
| PharmaEngine, Inc. | 347.3 Million TWD | -24.834% |
| Savior Lifetec Corporation | 219.6 Million TWD | -97.425% |
| TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | -151.731% |
| OBI Pharma, Inc. | -855.08 Million TWD | 150.703% |
| Meribank Biotech Co., Ltd | -92.56 Million TWD | 568.39% |
| Acepodia, Inc. | -764.51 Million TWD | 156.71% |
| Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | 194.233% |